Skip to content

Identifying Biomarkers in Alzheimer's Disease

Identifying Biomarkers in Alzheimer's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05655650
Acronym
SEEDS
Enrollment
300
Registered
2022-12-19
Start date
2018-09-01
Completion date
2030-12-31
Last updated
2022-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Neuro-Degenerative Disease

Keywords

Alzheimer Disease

Brief summary

Alzheimer's disease is a severe neurodegenerative disorder of the brain that is characterized by progressive loss of memory and cognitive decline. With the ageing population, AD is a major public health problem affecting nearly 35 million people worldwide with numbers projected to rise to 115.4 million by 2050. AD is the only cause of death among the top ten causes that has no prevention or cure . It is believed that novel treatment of AD needs to start early or even at the prodromal stage in order to be effective. Therefore, there is an urgent need to find accurate methods of early detection before patients with AD develop clinical dementia. This study aims to identify biomarkers for AD in local Chinese population. this study hypothesizes blood-based proteomics, retinal imaging, ASL-MRP and tau PET can improve the accuracy and staging of AD.

Detailed description

This is a cohort study. It involves baseline and 6 yearly follow ups. At baseline, all participants will go through a list of cognitive assessments, blood taking, Brain MRI scan, Brain PET scan and retinal imaging. At the first five yearly follow ups, cognitive assessment will be performed. For the sixth yearly follow up, automatic retinal image will be performed in addition to cognitive assessment.

Interventions

None listed

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Chinese ethnicity * \[For dementia group, clinical diagnosis of probable Alzheimer's disease according to recommendation from the National Institute on Aging-Alzheimer's Association workgroups (NIA-AA)

Exclusion criteria

* Clinical diagnosis of non-AD dementia * contraindication for MRI or PET

Design outcomes

Primary

MeasureTime frameDescription
The score change in Hong Kong List Learn Test (HKLLT)Baseline, 1 year, 2 year, 3 year ,4 year ,5 year and 6 year visit after baseline visitThe Hong Kong List Learn Test would be administered to assess the cognitive status for all group of study subjects
Amount of amyloid tau with T807 tracerBaselinePositron emission tomography imaging with T807 tracer would quantify the amount of tau protein. tau protein is one of the biomarkers associate with Alzheimer Disease
The score change in Montreal Cognitive Assessment Hong Kong (HK-MoCA)Baseline, 1 year, 2 year, 3 year ,4 year ,5 year and 6 year visit after baseline visitThe Montreal Cognitive Assessment Hong Kong would be administered to assess the cognitive status for all group of study subjects
The score change Clinical Dementia Rating (CDR)Baseline, 1 year, 2 year, 3 year ,4 year ,5 year and 6 year visit after baseline visitThe Clinical Dementia Rating would be administered to assess the cognitive status for all group of study subjects
Amount of amyloid β with 11C-Pittsburgh compound BBaselinePositron emission tomography imaging with 11C-Pittsburgh compound B would quantify the amount of amyloid β. Amyloid β is one of the biomarkers associate Alzheimer Disease
Amount of glucose hypometabolismBaselinePositron emission tomography imaging with 18F-FDG tracer would quantify the amount of glucose hypometabolism. glucose hypometabolism is one of the biomarkers associate with Alzheimer Disease
arterial spin labeling magnetic resonance perfusion (ASL-MRP)BaselineArterial spin labeling (ASL) perfusion is a MRI technique to quantify tissue blood flow of all group of subjects
Change of Automatic Retinal ImagingBaseline, 6th year follow upThere is a close anatomical correlation between both the macrovascular and the microvascular blood supply to the brain and the retina, and both vascular networks share similar vascular regulatory processes. Automatic Retinal Imaging is used to investigate microcirculations in retinal

Countries

Hong Kong

Contacts

Primary ContactPualine Kwan
paulinekwan@cuhk.edu.hk+852 26352160
Backup ContactElyia Han
elyiahan@cuhk.edu.hk+852 2697 5027

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026